During the past decade, CHU Brest Hopital La Cavale Blanche; Neurologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU Brest Hopital La Cavale Blanche; Neurologie" are "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "CHU Brest Hopital La Cavale Blanche; Neurologie" in a lesser frequency.

Most popular intervention types in "CHU Brest Hopital La Cavale Blanche; Neurologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Antihistamine" (1 trials), "Methylprednisolone" (1 trials), "Ocrelizumab" (1 trials), "Ocrelizumab 300 mg" (1 trials) and "Ocrelizumab 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Brest Hopital La Cavale Blanche; Neurologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU Brest Hopital La Cavale Blanche; Neurologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHU Brest Hopital La Cavale Blanche; Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Brest Hopital La Cavale Blanche; Neurologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".